The U.S. Food and Drug Administration has approved the PediNail Intramedullary nail for kids by OrthoPediatrics Corp. in May 2018. The rising incidence of bone fractures and deformity at the time of birth among children is a common scene today. Increasing incidence of bone fractures in places such as ulna, radius, tibia, and others, especially among children is a major factors promoting the growth of the global intramedullary nails market, finds Fortune Business Insights in their new report.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/intramedullary-nails-market-101162
Improving Healthcare Infrastructure to Help Market Expand in Europe and the Asia Pacific
Geographically, North America is anticipated to dominate the global intramedullary nails market in the forecast duration owing to rise in adoption of intramedullary nails, accompanied by the surge in cases of orthopedic injuries. Additionally, the increasing popularity of orthopedic implants and their wide adoption is presumed to boost the intramedullary nails market growth in North America and anticipated to continue doing so in the future years.
On the other hand, improving healthcare infrastructure and the advent of better medical equipment and diagnostic procedures in Europe and Asia Pacific will help these regions to generate attractive intramedullary nails market revenue in the near future.
Request a Sample Copy of the Global Intramedullary Nails Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/intramedullary-nails-market-101162
Food and Drug Administration Approvals to Bode Well for Market Players
The report highlights some of the major shareholders in the intramedullary nails market. These companies are mentioned below:
- Orthofix Holdings Inc.
- IMECO S.A.
- Johnson & Johnson Services Inc. (DePuy Synthes)
- Pega Medical Inc.
- Smith & Nephew
- Wright Medical Group N.V.
- Zimmer Biomet
- MEDIN a.s.
Market vendors are adopting various strategies to strengthen their market position. These include product innovations, up-gradation of existing products, company collaborations, merger and acquisitions, and others. Some of the successful innovations in the intramedullary nails market till date include:
January 2018 – The European CE Mark and the U.S. Food and Drug Administration announced the approval of Apex Tibial Nailing System, by OrthoXel DAC in January 2018.
February 2018 – The U.S. Food and Drug Administration approved Talon DistalFix Humeral Nail by Orthopedic Designs North America, Inc. in February 2018. This Humeral Nail is designed to aid in alignment and stabilization of humeral fractures.
Segmentation of the Global Intramedullary Nails Market
By Product Type
- Upper bone extremities
- Lower bone extremities
- Stainless steel
- Specialty clinics
- Ambulatory surgical centers
- North America (USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
More Trending Topics From Fortune Business [email protected]